Host genetic variation and its microbiome interactions within the Human Microbiome Project.

Abstract:

BACKGROUND:Despite the increasing recognition that microbial communities within the human body are linked to health, we have an incomplete understanding of the environmental and molecular interactions that shape the composition of these communities. Although host genetic factors play a role in these interactions, these factors have remained relatively unexplored given the requirement for large population-based cohorts in which both genotyping and microbiome characterization have been performed. METHODS:We performed whole-genome sequencing of 298 donors from the Human Microbiome Project (HMP) healthy cohort study to accompany existing deep characterization of their microbiomes at various body sites. This analysis yielded an average sequencing depth of 32x, with which we identified 27 million (M) single nucleotide variants and 2.3 M insertions-deletions. RESULTS:Taxonomic composition and functional potential of the microbiome covaried significantly with genetic principal components in the gastrointestinal tract and oral communities, but not in the nares or vaginal microbiota. Example associations included validation of known associations between FUT2 secretor status, as well as a variant conferring hypolactasia near the LCT gene, with Bifidobacterium longum abundance in stool. The associations of microbial features with both high-level genetic attributes and single variants were specific to particular body sites, highlighting the opportunity to find unique genetic mechanisms controlling microbiome properties in the microbial communities from multiple body sites. CONCLUSIONS:This study adds deep sequencing of host genomes to the body-wide microbiome sequences already extant from the HMP healthy cohort, creating a unique, versatile, and well-controlled reference for future studies seeking to identify host genetic modulators of the microbiome.

journal_name

Genome Med

journal_title

Genome medicine

authors

Kolde R,Franzosa EA,Rahnavard G,Hall AB,Vlamakis H,Stevens C,Daly MJ,Xavier RJ,Huttenhower C

doi

10.1186/s13073-018-0515-8

subject

Has Abstract

pub_date

2018-01-29 00:00:00

pages

6

issue

1

issn

1756-994X

pii

10.1186/s13073-018-0515-8

journal_volume

10

pub_type

杂志文章
  • Mining the literature: new methods to exploit keyword profiles.

    abstract:UNLABELLED:Bibliographic records in the PubMed database of biomedical literature are annotated with Medical Subject Headings (MeSH) by curators, which summarize the content of the articles. Two recent publications explain how to generate profiles of MeSH terms for a set of bibliographic records and to use them to defin...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm382

    authors: Andrade-Navarro MA

    更新日期:2012-10-30 00:00:00

  • Consensus: a framework for evaluation of uncertain gene variants in laboratory test reporting.

    abstract::Accurate interpretation of gene testing is a key component in customizing patient therapy. Where confirming evidence for a gene variant is lacking, computational prediction may be employed. A standardized framework, however, does not yet exist for quantitative evaluation of disease association for uncertain or novel g...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm347

    authors: Crockett DK,Ridge PG,Wilson AR,Lyon E,Williams MS,Narus SP,Facelli JC,Mitchell JA

    更新日期:2012-05-28 00:00:00

  • Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering.

    abstract:BACKGROUND:Comprehensive molecular profiling has revealed somatic variations in cancer at genomic, epigenomic, transcriptomic, and proteomic levels. The accumulating data has shown clearly that molecular phenotypes of cancer are complex and influenced by a multitude of factors. Conventional unsupervised clustering appl...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00804-8

    authors: Arora A,Olshen AB,Seshan VE,Shen R

    更新日期:2020-12-03 00:00:00

  • From small studies to precision medicine: prioritizing candidate biomarkers.

    abstract::There are still many open questions in data-analytic research pertaining to biomarker development in the era of personalized/precision medicine and big data. Among them is the question of what constitutes best practice for the extraction of prioritized lists of candidate biomarkers from smaller studies that are 'hypot...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm507

    authors: Gaile DP,Miecznikowski JC

    更新日期:2013-11-29 00:00:00

  • Clinical laboratory test-wide association scan of polygenic scores identifies biomarkers of complex disease.

    abstract:BACKGROUND:Clinical laboratory (lab) tests are used in clinical practice to diagnose, treat, and monitor disease conditions. Test results are stored in electronic health records (EHRs), and a growing number of EHRs are linked to patient DNA, offering unprecedented opportunities to query relationships between genetic ri...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00820-8

    authors: Dennis JK,Sealock JM,Straub P,Lee YH,Hucks D,Actkins K,Faucon A,Feng YA,Ge T,Goleva SB,Niarchou M,Singh K,Morley T,Smoller JW,Ruderfer DM,Mosley JD,Chen G,Davis LK

    更新日期:2021-01-13 00:00:00

  • Genetic and epigenetic insights into fetal alcohol spectrum disorders.

    abstract::The magnitude of the detrimental effects following in utero alcohol exposure, including fetal alcohol syndrome and other fetal alcohol spectrum disorders (FASD), is globally underestimated. The effects include irreversible cognitive and behavioral disabilities as a result of abnormal brain development, pre- and postna...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm148

    authors: Ramsay M

    更新日期:2010-04-28 00:00:00

  • Erratum to: a SNP profiling panel for sample tracking in whole-exome sequencing studies.

    abstract::This is an Erratum to Genome Medicine 2013, 5:89, highlighting an error in Table 1 of the original article. Please see related article: http://genomemedicine.com/content/5/9/89.[This corrects the article DOI: 10.1186/gm492.]. ...

    journal_title:Genome medicine

    pub_type: 已发布勘误

    doi:10.1186/s13073-015-0163-1

    authors: Pengelly RJ,Gibson J,Andreoletti G,Collins A,Mattocks CJ,Ennis S

    更新日期:2015-05-07 00:00:00

  • Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is the one of the most common cancers and lethal diseases in the world. DNA methylation alteration is frequently observed in HCC and may play important roles in carcinogenesis and diagnosis. METHODS:Using the TCGA HCC dataset, we classified HCC patients into different methylat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0548-z

    authors: Cheng J,Wei D,Ji Y,Chen L,Yang L,Li G,Wu L,Hou T,Xie L,Ding G,Li H,Li Y

    更新日期:2018-05-30 00:00:00

  • Hematopoietic stem cells, hematopoiesis and disease: lessons from the zebrafish model.

    abstract::The zebrafish model is rapidly gaining prominence in the study of development, hematopoiesis, and disease. The zebrafish provides distinct advantages over other vertebrate models during early embryonic development by producing transparent, externally fertilized embryos. Embryonic zebrafish are easily visualized and ma...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm299

    authors: Martin CS,Moriyama A,Zon LI

    更新日期:2011-12-29 00:00:00

  • Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.

    abstract:BACKGROUND:Based on promising phase II data, the histone deacetylase inhibitor entinostat is in phase III trials for patients with metastatic estrogen receptor-positive breast cancer. Predictors of sensitivity and resistance, however, remain unknown. METHODS:A total of eight cell lines and nine mouse models of breast ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0597-3

    authors: Tanioka M,Mott KR,Hollern DP,Fan C,Darr DB,Perou CM

    更新日期:2018-11-30 00:00:00

  • Personalizing carbamazepine therapy.

    abstract::The anticonvulsant carbamazepine has a high incidence of cutaneous adverse drug reactions. A recent prospective clinical trial in Taiwan has indicated that HLA-B*1502 screening will reduce the incidence of life-threatening adverse reactions to carbamazepine, while a genome-wide association study has identified the HLA...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm243

    authors: Mushiroda T,Nakamura Y

    更新日期:2011-05-30 00:00:00

  • Sharing knowledge: a new frontier for public-private partnerships in medicine.

    abstract::To help overcome the bottlenecks that limit the development of diagnostic and therapeutic products, academic and industrial researchers, patient organizations and charities, and regulatory and funding institutions should redefine the basis for sharing the knowledge collected in large-scale clinical and experimental st...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm29

    authors: Auffray C

    更新日期:2009-03-04 00:00:00

  • Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex.

    abstract:BACKGROUND:A comprehensive understanding of the pre-existing genetic variation in genes associated with antibiotic resistance in the Mycobacterium tuberculosis complex (MTBC) is needed to accurately interpret whole-genome sequencing data for genotypic drug susceptibility testing (DST). METHODS:We investigated mutation...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00726-5

    authors: Merker M,Kohl TA,Barilar I,Andres S,Fowler PW,Chryssanthou E,Ängeby K,Jureen P,Moradigaravand D,Parkhill J,Peacock SJ,Schön T,Maurer FP,Walker T,Köser C,Niemann S

    更新日期:2020-03-06 00:00:00

  • Comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe.

    abstract:BACKGROUND:Expression quantitative trait loci (eQTL) analysis is a powerful method to detect correlations between gene expression and genomic variants and is widely used to interpret the biological mechanism underlying identified genome wide association studies (GWAS) risk loci. Numerous eQTL studies have been performe...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-016-0320-1

    authors: Blauwendraat C,Francescatto M,Gibbs JR,Jansen IE,Simón-Sánchez J,Hernandez DG,Dillman AA,Singleton AB,Cookson MR,Rizzu P,Heutink P

    更新日期:2016-06-10 00:00:00

  • NGS-Logistics: federated analysis of NGS sequence variants across multiple locations.

    abstract::As many personal genomes are being sequenced, collaborative analysis of those genomes has become essential. However, analysis of personal genomic data raises important privacy and confidentiality issues. We propose a methodology for federated analysis of sequence variants from personal genomes. Specific base-pair posi...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-014-0071-9

    authors: Ardeshirdavani A,Souche E,Dehaspe L,Van Houdt J,Vermeesch JR,Moreau Y

    更新日期:2014-09-17 00:00:00

  • Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases.

    abstract::The number of metabolites identified in human cerebrospinal fluid (CSF) has steadily increased over the past 5 years, and in this issue of Genome Medicine David Wishart and colleagues provide a comprehensive update that brings the number of metabolites listed in the CSF metabolome database to 476 compounds. There is n...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm338

    authors: Schwarz E,Torrey EF,Guest PC,Bahn S

    更新日期:2012-04-30 00:00:00

  • Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression.

    abstract:BACKGROUND:Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) are characterised by abnormal epigenetic repression and differentiation of bone marrow haematopoietic stem cells (HSCs). Drugs that reverse epigenetic repression, such as 5-azacytidine (5-AZA), induce haematological improvement in half of trea...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0707-x

    authors: Kazachenka A,Young GR,Attig J,Kordella C,Lamprianidou E,Zoulia E,Vrachiolias G,Papoutselis M,Bernard E,Papaemmanuil E,Kotsianidis I,Kassiotis G

    更新日期:2019-12-23 00:00:00

  • Overcoming bias and systematic errors in next generation sequencing data.

    abstract::Considerable time and effort has been spent in developing analysis and quality assessment methods to allow the use of microarrays in a clinical setting. As is the case for microarrays and other high-throughput technologies, data from new high-throughput sequencing technologies are subject to technological and biologic...

    journal_title:Genome medicine

    pub_type: 社论

    doi:10.1186/gm208

    authors: Taub MA,Corrada Bravo H,Irizarry RA

    更新日期:2010-12-10 00:00:00

  • MeCP2 mutations: progress towards understanding and treating Rett syndrome.

    abstract::Rett syndrome is a profound neurological disorder caused by mutations in the MECP2 gene, but preclinical research has indicated that it is potentially treatable. Progress towards this goal depends on the development of increasingly relevant model systems and on our improving knowledge of MeCP2 function in the brain. ...

    journal_title:Genome medicine

    pub_type: 信件,评审

    doi:10.1186/s13073-017-0411-7

    authors: Shah RR,Bird AP

    更新日期:2017-02-17 00:00:00

  • Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci.

    abstract:BACKGROUND:Systemic sclerosis (SSc) is a genetically complex autoimmune disease mediated by the interplay between genetic and epigenetic factors in a multitude of immune cells, with CD4+ T lymphocytes as one of the principle drivers of pathogenesis. METHODS:DNA samples exacted from CD4+ T cells of 48 SSc patients and ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00779-6

    authors: Li T,Ortiz-Fernández L,Andrés-León E,Ciudad L,Javierre BM,López-Isac E,Guillén-Del-Castillo A,Simeón-Aznar CP,Ballestar E,Martin J

    更新日期:2020-09-25 00:00:00

  • Pharmacogenomics of adverse drug reactions.

    abstract::Considerable progress has been made in identifying genetic risk factors for idiosyncratic adverse drug reactions in the past 30 years. These reactions can affect various tissues and organs, including liver, skin, muscle and heart, in a drug-dependent manner. Using both candidate gene and genome-wide association studie...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm409

    authors: Daly AK

    更新日期:2013-01-29 00:00:00

  • Genetic relatedness analysis reveals the cotransmission of genetically related Plasmodium falciparum parasites in Thiès, Senegal.

    abstract:BACKGROUND:As public health interventions drive parasite populations to elimination, genetic epidemiology models that incorporate population genomics can be powerful tools for evaluating the effectiveness of continued intervention. However, current genetic epidemiology models may not accurately simulate the population ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0398-0

    authors: Wong W,Griggs AD,Daniels RF,Schaffner SF,Ndiaye D,Bei AK,Deme AB,MacInnis B,Volkman SK,Hartl DL,Neafsey DE,Wirth DF

    更新日期:2017-01-24 00:00:00

  • Genomic variants associated with primary biliary cirrhosis.

    abstract::Primary biliary cirrhosis (PBC) is an autoimmune hepatobiliary disease characterized by immune-mediated injury of small and medium-sized bile ducts, eventually leading to liver cirrhosis. Several studies have addressed PBC immunopathology, and the data support an immune activation leading to autoantibodies and autorea...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm126

    authors: Selmi C,Torok NJ,Affronti A,Gershwin ME

    更新日期:2010-01-26 00:00:00

  • Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance.

    abstract::Advances in mass spectrometry have allowed the high-throughput quantitative identification of human leukocyte antigen (HLA) class I ligands, and recent studies have reported on the breadth and diversity of the HLA class I immunopeptidome. These findings have far-reaching implications for immunosurveillance by T cells ...

    journal_title:Genome medicine

    pub_type: 社论,评审

    doi:10.1186/s13073-017-0439-8

    authors: Melief CJM,Kessler JH

    更新日期:2017-05-24 00:00:00

  • Text-mining clinically relevant cancer biomarkers for curation into the CIViC database.

    abstract:BACKGROUND:Precision oncology involves analysis of individual cancer samples to understand the genes and pathways involved in the development and progression of a cancer. To improve patient care, knowledge of diagnostic, prognostic, predisposing, and drug response markers is essential. Several knowledgebases have been ...

    journal_title:Genome medicine

    pub_type: 杂志文章,meta分析

    doi:10.1186/s13073-019-0686-y

    authors: Lever J,Jones MR,Danos AM,Krysiak K,Bonakdar M,Grewal JK,Culibrk L,Griffith OL,Griffith M,Jones SJM

    更新日期:2019-12-03 00:00:00

  • Prenatal diagnosis of fetal aneuploidies: post-genomic developments.

    abstract::Prenatal diagnosis of fetal aneuploidies and chromosomal anomalies is likely to undergo a profound change in the near future. On the one hand this is mediated by new technical developments, such as chromosomal microarrays, which allow a much more precise delineation of minute sub-microscopic chromosomal aberrancies th...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm171

    authors: Hahn S,Jackson LG,Zimmermann BG

    更新日期:2010-08-05 00:00:00

  • CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling.

    abstract::CRISPR/Cas9 has revolutionized cancer mouse models. Although loss-of-function genetics by CRISPR/Cas9 is well-established, generating gain-of-function alleles in somatic cancer models is still challenging because of the low efficiency of gene knock-in. Here we developed CRISPR-based Somatic Oncogene kNock-In for Cance...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0627-9

    authors: Mou H,Ozata DM,Smith JL,Sheel A,Kwan SY,Hough S,Kucukural A,Kennedy Z,Cao Y,Xue W

    更新日期:2019-04-16 00:00:00

  • Genomics and the classification of mental illness: focus on broader categories.

    abstract::Coinciding with the release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, two recently published molecular genetics analyses suggest large overlaps in genetic liability to schizophrenia, bipolar disorder and major depressive disorder. This indicates that a broader category of sever...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm501

    authors: Uher R

    更新日期:2013-10-25 00:00:00

  • Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine.

    abstract::Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an increasing number of randomized controlled trials. Recently published data gives striking insights into the factors associated with FMT success paving the road for the use of prec...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00757-y

    authors: Benech N,Sokol H

    更新日期:2020-06-30 00:00:00

  • Actionable gene-based classification toward precision medicine in gastric cancer.

    abstract:BACKGROUND:Intertumoral heterogeneity represents a significant hurdle to identifying optimized targeted therapies in gastric cancer (GC). To realize precision medicine for GC patients, an actionable gene alteration-based molecular classification that directly associates GCs with targeted therapies is needed. METHODS:A...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0484-3

    authors: Ichikawa H,Nagahashi M,Shimada Y,Hanyu T,Ishikawa T,Kameyama H,Kobayashi T,Sakata J,Yabusaki H,Nakagawa S,Sato N,Hirata Y,Kitagawa Y,Tanahashi T,Yoshida K,Nakanishi R,Oki E,Vuzman D,Lyle S,Takabe K,Ling Y,Okuda

    更新日期:2017-10-31 00:00:00